Transgenic transchromosomal rodents for making human antibodies

Details Transgenic transchromosomal rodents for making human antibodies Transgenic transchromosomal rodents for making human antibodies

2005-09-30

2009-08-18

Li, Q. Janice (Department: 1633)

Multicellular living organisms and unmodified parts thereof and

Method of using a transgenic nonhuman animal to manufacture...

The protein is isolated or extracted from blood or serum

C800S004000, C800S005000, C800S013000, C800S018000, C800S021000, C800S025000

Reexamination Certificate

active

07576258

ABSTRACT:
The present invention provides novel transgenic nonhuman mammals capable of producing human sequence antibodies, as well as methods of producing and using these antibodies.

REFERENCES:
patent: 5175384 (1992-12-01), Krimpenfort
patent: 5204244 (1993-04-01), Fell et al.
patent: 5416260 (1995-05-01), Jikker
patent: 5434340 (1995-07-01), Krimpenfort
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5698196 (1997-12-01), Matsushima
patent: 5702946 (1997-12-01), Doerschuk
patent: 5770429 (1998-06-01), Lonberg et al.
patent: 5789650 (1998-08-01), Lonberg et al.
patent: 5814318 (1998-09-01), Lonberg et al.
patent: 5874299 (1999-02-01), Lonberg et al.
patent: 5877397 (1999-03-01), Lonberg et al.
patent: 5939598 (1999-08-01), Kucherlapati et al.
patent: 6162963 (2000-12-01), Kucherlapati et al.
patent: 6300129 (2001-10-01), Lonberg et al.
patent: 6632976 (2003-10-01), Tomizuka et al.
patent: 2003/0093820 (2003-05-01), Green et al.
patent: 0 315 062 (1989-05-01), None
patent: 0 773 288 (1997-05-01), None
patent: 0 843 961 (1998-05-01), None
patent: 0 972 445 (2000-01-01), None
patent: 1 106 061 (2000-06-01), None
patent: 1 206 906 (2002-05-01), None
patent: WO 90/04036 (1990-04-01), None
patent: WO 90/12878 (1990-11-01), None
patent: WO 91/00906 (1991-01-01), None
patent: WO 91/10741 (1991-07-01), None
patent: WO 92/03918 (1992-03-01), None
patent: WO 96/02576 (1996-02-01), None
patent: WO 02/43478 (2002-06-01), None
Mullins et al, J Clin Invest Apr. 1996;97:1557-60.
Wall et al, J Dairy Sci 1997;80:2213-24.
Sigmund, Arteroscler. Throm. Vasc. Biol. 2000;20:1425-9.
Niemann, Transg. Res. 1998, 7, p. 73-.
Donovan and Gearhart, Nat Nov. 2001;414:92-97.
Denning et al, Nat Biotech 2001;19:559-562.
Tomizuka et al, PNAS Jan. 2000;97:722-7.
Nielsen et al, J Cell Biochem. Jan. 2000;76(4):674-85.
Fishwild et al, Nat Biotechnol 1996;14:845-51.
Tomizuka et al, Nat Genetics 1997;16:133-43.
Green et al, J Immunol Methods 1999;231:11-23.
Wang et al, J Immunol Methods 2000;244:217-25.
Den et al, J Immunol Methods 1999;222:45-7.
Bolland et al, Immunity 2000;13:277-85.
Houdebine, (1994) J. Biotech. 34, p. 281.
Linder, Lab Animal May 2001;30:34-9.
Logan and Sharma, Clin Exp Pharmacol Physiol Dec. 1999;26:1020-25.
Hammer et al, J Anim Sci 1986;63:269-78.
Taylor, et al. “A Transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins” Oxford University Press, Nucleic Acids Res., 1992, vol. 20 No. 23, pp. 6287-6295.
Aya Jakovits, “Production and selection of antigen -specific fully human monoclonal antibodies from mice engineered with human Ig loci.” Advanced Drug Reviews 31, 1998 pp. 31-42.
Alt, F.W., et al., “Immunoglobulin genes in transgenic mice”,Trends in Genetics, 231-236, (Aug. 1985).
Berman, J.E., et. al., “Content and organization of the human Ig VHlocus: definition of three new VHfamilies and linkage to the Ig CHlocus”,The EMBO J. 7:727-738 (1988).
Berton, M.T., et. al., “Synthesis of germ-line .γ1 immunoglobulin heavy-chain transcripts in resting B cells: Induction by interleukin 4 and inhibition by interferon γ.”,Proc. Natl. Acad. Sci. (U.S.A.) 86:2829-2833 (1989).
Bollag, R.J., et al., “Homologous recombination in mammalian cells”,Annu. Rev. Genet. 23:199-225 (1989).
Bruggemann, M., et al., “A repertoire of monoclonal antibodies with human heavy chains from transgenic mice”,Proc. Natl. Acad. Sci. USA86:6709-6713 (1989).
Bruggemann, M., et al., “Human antibody production in transgenic mice: expression from 100 kb of the human IgH locus”,Eur. J. Immunol. 21:1323-1326 (1991).
Bucchini, D., et al., “Rearrangement of a chicken immunoglobulin gene occurs in the lymphoid lineage of transgenic mice”,Nature326:409-411 (1987).
Buttin, G.,, “Exogenous Ig gene rearrangement in transgenic mice: a new strategy for human monoclonal antibody production?”Trends in Genetics—vol. 3, No. 8, 205-206 (Aug. 1987).
Capecchi, M.R., “Altering the genome by homologous recombination”,Science244:1288-1292 (1989).
Capecchi, M.R., “The new mouse genetics: Altering the genome by gene targeting”,Trends in Genetics5:70-76 (1989).
Choi, T.K., et al., “Transgenic mice containing a human heavy chain immunoglobulin gene fragment cloned in a yeast artificial chromosome.”Nat Genet. Jun. 1993;4(2):117-23.
Coffman, R.L., et al., “A mouse T cell product that preferentially enhances IgA production”,J. Immunol. 139:3685-3690 (1987).
Coffman, R.L., and Carty, J, “A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-γ”,J. Immunol. 136:949-954 (1986).
Davies, N.P., et al., “Creation of Mice Expressing Human Atibody Light Chains by Introduction of a Yeast Artificial Chromosome Containing the Core Region of the Human Immunoglobulin κ Locus.”Biotechnology(N Y). Aug. 1993;11(8):911-4.
Davies, N.P., et al., “Targeted Alterations in Yeast Artificial Chromosomes for Inter-Species Gene Transfer”,Nucleic Acid Res. 20: 2693-2698 (1992).
Doetschman, T., et al., “Targetted correction of a mutant HPRT gene in mouse embryonic stem cells”,Nature330:576-578 (1987).
Durdik, J., et al., “Isotype switching by a microinjected μ immunoglobulin heavy chain gene in transgenic mice”,Proc. Natl. Acad. Sci. USA86:2346-2350 (1989).
Esser, C., and Radbruch, A., “Rapid induction of transcription of unrearranged Sγ1 switch regions in activated murine B cells by interleukin 4”,The EMBO J. 8:483-488 (1989).
Ferrier, P., et al., “Separate elements control DJ and VDJ rearrangement in a transgenic recombination substrate”,The EMBO J. 9:117-125 (1990).
Fishwild, D.M., et al. “High-Avidity human IgGκ monoclonal antibodies from a novel strain of minilocus transgenic mice”,Nature Biotechnology14:845. (1996).
Forni, L., “Extensive splenic B cell activation in IgM-transgenic mice”,Eur. J. Immunol. 20:983-989 (1990).
Gerstein, R.M., et al., “Isotype Switching of an Immunoglobulin Heavy Chain Transgene Occurs by DNA Recombination between Different Chromosomes”,Cell63:537-548 (1990).
Goodhardt, M., et al., “Rearrangement and expression of rabbit immunoglobulin κ light chain gene in transgenic mice”,Proc. Natl. Acad. Sci.(U.S.A.) 84:4229-4233 (1987).
Gordon, J., “Transgenic mice in immunology”,The Mount Sinai Journal of Medicine, 53:223-231 (1986).
Green, L.L., et al., “Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs”,Nature Genetics7:13-21 (1994).
Hagman, J., et al., “Inhibition of immunoglobulin gene rearrangement by the expression of a .λ2 transgene”,J. Exp. Med. 169:1911-1929 (1989).
Hofker, M.H., et al., “Complete physical map of the human immunoglobulin heavy chain constant region gene complex”,Proc. Natl. Acad. Sci. USA86:5567-5571 (1989).
Humphries, C.G., et al., “A new human immunoglobulin VHfamily preferentially rearranged in immature B-cell tumours”,Nature331:446-449 (1988).
Huxley, C., et al., “The human HPRT gene on a yeast artificial chromosome is functional when transferred to mouse cells by cell fusion.”GenomicsApr. 1991;9(4):742-50.
Ichihara, Y., et al., “Organization of human immunoglobulin heavy chain diversity gene loci”,The EMBO J. 7:4141-4150 (1988).
Iglesias, A., et al., “Expression of immunoglobulin delta chain causes allelic exclusion in transgenic mice”,Nature330:482-484 (1987).
Jaenisch, R.,“Transgenic Animals”,Science240:1468-1474 (1988).
Jakobovits, A., et al., “Analysis of hom

Affiliated with

Also associated with

Rating

Transgenic transchromosomal rodents for making human antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transgenic transchromosomal rodents for making human antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic transchromosomal rodents for making human antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4082035